5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer.

Trial Profile

5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jun 2013 Status changed from active, no longer recruiting to discontinued according to results presented at ASCO 2013.
    • 05 Jun 2009 Interim results reported at the 45th Annual Meeting of the American Society of Clinical Oncology.
    • 05 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top